Abstract
LBA86 Androgen receptor pathway inhibitors or taxanes for patients with metastatic castration-resistant prostate cancer: A direct comparison in ProBio, a randomized, outcome-adaptive, biomarker-driven platform trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have